| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,0 M € | -6.9% | 15,1 M € | +17.4% | 12,9 M € | +8.8% | 11,8 M € | -20.8% | 14,9 M € | +19.2% | 12,5 M € | +48.9% | 8,4 M € | +21.6% | 6,9 M € | +11.5% | 6,2 M € | +1280.1% | 449,5 k € | +31.2% | 342,7 k € | -41.1% | 581,3 k € | -16.3% | 694,7 k € | +43.2% | 485,1 k € | +24.0% | 391,4 k € | -71.3% | 1,4 M € | +247.6% | 392,4 k € | +92.4% | 203,9 k € | |
| EBITDA | 6,2 M € | -11.6% | 7,1 M € | +13.8% | 6,2 M € | +42.6% | 4,3 M € | -36.5% | 6,8 M € | +13.0% | 6,1 M € | +112.6% | 2,8 M € | +38.1% | 2,1 M € | +24.4% | 1,7 M € | -31.0% | 2,4 M € | +51.6% | 1,6 M € | +60.9% | 984,9 k € | -24.6% | 1,3 M € | +115.8% | 605,1 k € | -17.6% | 734,6 k € | -53.1% | 1,6 M € | +2417.1% | 62,2 k € | -73.3% | 232,9 k € | |
| Operating profit | 6,2 M € | -11.5% | 7,0 M € | +13.9% | 6,1 M € | +43.1% | 4,3 M € | -37.5% | 6,8 M € | +13.0% | 6,0 M € | +112.9% | 2,8 M € | +38.2% | 2,1 M € | +24.1% | 1,7 M € | -31.0% | 2,4 M € | +51.1% | 1,6 M € | +63.1% | 973,5 k € | -24.7% | 1,3 M € | +114.8% | 601,6 k € | -15.0% | 707,5 k € | -53.9% | 1,5 M € | +6048.0% | 25,0 k € | -87.7% | 202,9 k € | |
| Profit/loss | 4,7 M € | -12.2% | 5,3 M € | +17.0% | 4,5 M € | +43.3% | 3,2 M € | -38.0% | 5,1 M € | +14.5% | 4,5 M € | +133.7% | 1,9 M € | +32.7% | 1,4 M € | +28.9% | 1,1 M € | -29.2% | 1,6 M € | +55.5% | 1,0 M € | +63.2% | 620,1 k € | -18.3% | 758,9 k € | +89.3% | 400,9 k € | -10.0% | 445,3 k € | -53.9% | 965,1 k € | +2889.3% | -34,6 k € | -131.5% | 109,9 k € | |
| Equity | 1,4 M € | +85.0% | 780,2 k € | +66.1% | 469,9 k € | -49.5% | 929,7 k € | +21.9% | 762,4 k € | +16.1% | 656,8 k € | +229.5% | 199,3 k € | +3.7% | 192,3 k € | +23.6% | 155,6 k € | -96.9% | 5,0 M € | +45.4% | 3,5 M € | +41.2% | 2,5 M € | +33.8% | 1,8 M € | +70.6% | 1,1 M € | +59.4% | 674,7 k € | -32.7% | 1,0 M € | +2620.7% | 36,8 k € | -78.5% | 171,4 k € | |
| Total assets | 6,8 M € | -4.3% | 7,1 M € | +5.5% | 6,8 M € | +28.2% | 5,3 M € | -25.5% | 7,1 M € | +15.8% | 6,1 M € | +39.4% | 4,4 M € | +61.7% | 2,7 M € | -60.9% | 6,9 M € | +16.4% | 6,0 M € | +42.3% | 4,2 M € | +35.9% | 3,1 M € | +27.7% | 2,4 M € | +49.8% | 1,6 M € | -29.9% | 2,3 M € | -10.5% | 2,6 M € | +106.2% | 1,2 M € | +32.2% | 941,5 k € | |
| Cash | — | — | — | — | — | 13,8 k € | — | — | — | — | — | — | — | 295,0 € | — | — | 192,4 k € | — | ||||||||||||||||||
| Debts | 5,4 M € | -15.1% | 6,3 M € | +0.9% | 6,3 M € | +44.8% | 4,3 M € | -31.3% | 6,3 M € | +15.7% | 5,5 M € | +30.4% | 4,2 M € | +66.2% | 2,5 M € | -62.9% | 6,8 M € | +638.0% | 918,9 k € | +27.2% | 722,2 k € | +15.2% | 627,2 k € | +12.8% | 555,8 k € | +3.9% | 535,1 k € | -67.0% | 1,6 M € | +34.2% | 1,2 M € | +33.5% | 906,2 k € | +17.7% | 770,1 k € | |
| Staff | 32,5 | 33,8 | 39,3 | 42,6 | 32,9 | 26 | 22,1 | 17,9 | 16,8 | 16,5 | 16,2 | 16,3 | 16,9 | 16,7 | 16,4 | 15,4 | 15,6 | 14 | ||||||||||||||||||
Public limited company · Woluwe-Saint-Lambert · incorporated on 03/04/2007 · 32,5 ETP
Public limited company profitable but thinly capitalised. Cash position rising (+4585.1%).
Solid counterparty for a standard engagement.
SARTORIUS STEDIM BELGIUM is a Public limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Woluwe-Saint-Lambert. It employs on average 32,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette